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Transplanted stemcells can induce and enhance functional recovery in experimental stroke.
Invasive analysis has been extensively used to provide detailed cellular and molecular
characterization of the stroke pathology and engrafted stem cells. But postmortem analysis
is not appropriate to reveal the time scale of the dynamic interplay between the cell graft,
the ischemic lesion and the endogenous repair mechanisms. This review describes non-
invasive imaging techniques which have been developed to provide complementary in vivo
information. Recent advances were made in analyzing simultaneously different aspects of
the cell graft (e.g., number of cells, viability state, and cell fate), the ischemic lesion (e.g.,
blood–brain-barrier consistency, hypoxic, and necrotic areas) and the neuronal and vascular
network.We focus on optical methods, which permit simple animal preparation, repetitive
experimental conditions, relatively medium-cost instrumentation and are performed under
mild anesthesia, thus nearly under physiological conditions. A selection of recent examples
of optical intrinsic imaging, ﬂuorescence imaging and bioluminescence imaging to charac-
terize the stroke pathology and engrafted stem cells are discussed. Special attention is paid
to novel optimal reporter genes/probes for genetic labeling and tracking of stem cells and
appropriate transgenic animal models. Requirements, advantages and limitations of these
imaging platforms are critically discussed and placed into the context of other non-invasive
techniques, e.g., magnetic resonance imaging and positron emission tomography, which
can be joined with optical imaging in multimodal approaches.
Keywords: optical neuroimaging, non-invasive, stem cell therapy, stroke, bioluminescence imaging, fluorescence
imaging
INTRODUCTION
The stroke pathology and regeneration processes induced by
endogenousmechanisms or engrafted stem cells have been studied
extensively. Invasive studies – including immunohistochemistry,
autoradiography, electrophysiology, and molecular biology –
revealed the ischemic cascade of pathological and protective sig-
naling events (Zhang and Chopp, 2009; Iadecola and Anrather,
2011). New neurons are found in the rat striatum after exper-
imental stroke (Arvidsson et al., 2002), but neurogenesis and
functional neuronal integration seem alone not to be able to
restore brain function. In this line, exogenous stem cells, e.g.,
neural stem cells (NSCs) derived from embryonic or induced-
pluripotent stem cells, have been implanted in experimental
rodent models of stroke and found to increase functional recov-
ery in many studies (Bliss et al., 2007; Oki et al., 2012). However,
the interplay of stem cells with the injured host tissue and the
mode of action of engrafted cells in the longitudinal time pro-
ﬁle of stroke regeneration have to be deciphered before clinical
translation.
We review here optical imaging as one promising approach
to shed new light on structural and functional components of
stem cell therapy in stroke. We introduced ﬂuorescence and bio-
luminescence imaging (FLI and BLI) which have been extensively
developed in the last decade to meet the criteria of a highly sen-
sitive and minimally invasive set-up (Figure 1). We provide a
selection of recent publications related to stroke and/or stem cell
transplantation in rodents, whichwe ﬁnd appropriate to introduce
current possibilities and constraints of optical neuroimaging. In
addition, selected references – in line with most preclinical opti-
cal imaging studies – refer to mice or rats and exclude, e.g., stroke
studies in non-human primates (Bihel et al., 2010) or the zebraﬁsh
(Walcott and Peterson, 2014).
OPTICAL NEUROIMAGING
Molecular imaging aims to visualize cellular and molec-
ular events – related to physiological or pathophysiological
processes – in the living subject, e.g., by genetically linked imaging
reporters (Massoud et al., 2008a). Based on the ﬁrst non-invasive
experiments with superﬁcial sources, optical neuroimaging has
been so far most effectively implemented for brain tumor stud-
ies (Massoud et al., 2008b) and less for neurological disease
models or endogenous/exogenous NSCs in which sensitivity is
essential. Compared to superﬁcial sources, the brain appears
to be a very difﬁcult organ to be penetrated and explored by
light. The natural multilayer barrier of blood, meninges, bone
and skin covers all neural cells. Despite the extensive techni-
cal developments in optical imaging, major challenges of light
absorption and scattering, autoﬂuorescence, low spectral reso-
lution and quantiﬁcation still need to be considered (Shah and
Weissleder, 2005; Hillman, 2007; Sutton et al., 2008). Among
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FIGURE 1 | Optical neuroimaging strategies to target the stroke
pathology and regeneration processes upon stem cell grafting.
Two-photon microscopy (2PM) can be used to monitor blood ﬂow changes
during the acute phase, as well as changes in the cortical neuronal network
over time. Optical intrinsic imaging utilizes the different absorption behavior of
oxygenated (HbO2) and deoxygenated hemoglobin (HbR) to resolve changes
in blood ﬂow. Near-infrared probes have been designed to target, e.g.,
apoptotic cells or immune cells speciﬁcally by ﬂuorescence imaging (FLI).
Functional reorganization can be monitored by application of voltage-sensitive
dye (VSD) imaging. Transplanted stem cells expressing bioluminescence and
ﬂuorescence imaging reporters allow longitudinal monitoring by
bioluminescence imaging (BLI) and histological validation.
these physical limitations, light absorption and scattering are the
main cause that affects in vivo optical approaches. Absorption
is mainly driven by pigments/chromophores (hemoglobin and
bilirubin in the blood, myoglobin in the muscles, pheo- and
eumelanin in the skin) and also by water and lipids (Figure 2).
Brain tissue requires continuous blood supply, which implies
strong light attenuation by absorption. Efﬁcient light propaga-
tion through the brain is provided in a naturally existing window
of low absorption in the near-infrared (NIR, ∼700–900 nm;
Frangioni, 2003). Despite absorption effects, light is scattered
at inter- and intracellular membrane boundaries due to differ-
ences in the refractive index n (ratio of the speed of light in
vacuum and speed of light in the material), e.g., extracellular ﬂu-
ids (n = 1.335) and triglycerides (n = 1.491; Ross, 1967). The
brain parenchyma is composed of many of these speciﬁc bound-
aries, most prominently white and gray matter, leading to light
scatter. Improving the imaging set-up, e.g., by advanced tech-
nical devices or imaging reporters with higher sensitivity will
certainly facilitate imaging in small animals. But it should be
noted that the physical factors leading to light attenuation and
scattering and the insertion of an imaging transgene deﬁnitely
limit the application on small animals and preclude optical neu-
roimaging in humans. As this review is focused on recent optical
imaging applications but not on the physical principles, we refer
the interested reader to a technical review of Schulz and Semmler
(2008) and the comprehensive book Molecular imaging: Princi-
ples and Practice edited by Weissleder and Gambhir (2010). The
following two chapters introduce FLI and BLI techniques with a
focus on optical neuroimaging, describe useful imaging reporters
and recent studies. Finally, we discuss the importance of cell-
speciﬁc imaging and the beneﬁt of combining different imaging
techniques.
FLUORESCENCE IMAGING
In vivo FLI uses a set-up similar to ﬂuorescence microscopy
consisting of a light source, ﬂuorescence ﬁlters and a sensitive
charge-coupled device (CCD) camera. But in addition, the set-up
is housed in a light-tight chamber to collect ﬂuorescence emis-
sion exclusively from the anesthetized animal at the macroscopic
level (Rao et al., 2007). To penetrate the mouse skull efﬁciently,
excitation with NIR laser light either through the mouse head
[transillumination ﬂuorescence imaging (TFI)] or from top [ﬂu-
orescence reﬂectance imaging (FRI)] is applied (Frangioni, 2003;
Klohs et al., 2006). New systems can perform transillumination
while the mouse is rotated through 360◦ to allow photon acquisi-
tion from multiple projections [ﬂuorescence tomography (FMT);
Deliolanis and Ntziachristos, 2013]. Nevertheless, some applica-
tions still require exposure of the skull and removal of the skin. In
general, only NIR ﬂuorescence is efﬁcient enough for in vivo neu-
roimaging due to the strong attenuation of shorter wavelengths
(<700 nm). FLI has been adapted to the mouse brain application
in the micro- and macroscale to visualize stem cells or stroke-
related functional changes based on ﬂuorescent proteins (FPs),
ﬂuorescent dyes, and endogenous chromophores.
FLUORESCENCE PROTEINS
The discovery of the green FP (GFP) from the jellyﬁsh Aequorea
victoria paved theway for a universalmarker for cell structures and
cellular processes detectable by ﬂuorescence microscopy (Chalﬁe
et al., 1994). The diversity of FPs has increased since then tremen-
dously by mutating the original GFP sequence and cloning FP
from distant species like crustaceans. Such FPs can be expressed in
mammalian cells, including stemcells and transgenicmicewithout
signs of toxicity (Shaner et al., 2005). Smartmulti-label approaches
like the brainbow toolbox have been developed to mark neurons
with many different FPs (Cai et al., 2013). However, in vivo FLI is
challenged by a variety of factors: the excitation/emission wave-
length, the brightness being determined by the quantumyield (QY,
the ratio of photons emitted to photons absorbed during excita-
tion), the extinction coefﬁcient (EC, determining how strongly
light is absorbed), the FP maturation rate, photostability, pH
stability, and aggregation potential (Chudakov et al., 2010). FPs
for in vivo neuroimaging will proﬁt from novel – much more
efﬁcient – NIR probes (Shcherbakova and Verkhusha, 2013).
FLUORESCENT DYES
Several chemical probes have proven long term labeling of stem
cells, including chloromethylﬂuorescein diacetate (CMFDA or
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FIGURE 2 |Wavelength-dependent absorption in tissue restricts the
optical imaging spectrum. Light absorption by hemoglobin, melanin, lipids
and water is wavelength-dependent. Differences can be used to discriminate,
e.g., oxy- and deoxyhemoglobin by spectral analysis. A window of low
absorption exists in the near-infrared range (∼700–900 nm). Absorption and
extinction coefﬁcients from Palmer andWilliams (1974), Cheong et al. (1990),
Pope and Fry (1997), Prahl (1999) and Sarna and Swartz (2006), displayed in
log scale.
CellTracker) and long chain carbocyanine dyes (likeDiI,DiO,DiD,
and CM-DiI; Sutton et al., 2008; Mäkinen et al., 2013; Boehm-
Sturm et al., 2014). CMFDAandDiD labels were found to be stable
for up to 4 weeks in human ES-cell derived neural cells in vitro
(Mäkinen et al., 2013). Stem cell labeling prior to implantation
is efﬁcient but cell tracking is restricted to ex vivo ﬂuorescence
microscopy (Jablonska et al., 2010; Boehm-Sturm et al., 2014).
In vivo data has been acquired with NIR cyanine dyes (Cy) –
especially Cy5.5 (excitation 675 nm, emission 694 nm). Targeted
probes have been designed to visualize key components of the
stroke pathology. Inﬂammatory processes are monitored by an
ﬂuorescence-labeled antibody against the inﬂammatory receptor
CD40 expressed on immune cells (Klohs et al., 2008) and dead cells
can be targeted by the cell death marker Annexin A5 (Bahmani
et al., 2011). In addition, Zhang et al. (2012) investigated an opti-
calmethod to detect ﬁbrin deposition,which leads to thrombosis –
responsible for 80% of human stroke. In a mouse model of throm-
boembolic stroke, aNIRprobewas injected,which is recognized by
the activated coagulation factor XIII (FXIIIa), an important medi-
ator of thrombosis or ﬁbrinolytic resistance (Figure 3). Numerous
probes have the potential to visualize stroke-related pathologies
and host reactions, e.g., blood–brain-barrier (BBB) breakdown,
inﬁltrating immune cells and (de-) myelination (Wang et al., 2011;
Eaton et al., 2013) but have not been tested in animal models of
stroke yet. NIR probes have been successfully used to simulta-
neously image cell death and BBB-disruption in traumatic brain
injury (Smith et al., 2012). Smart probes have been designed to
report activity of matrix metalloproteinases, which are highly
upregulated after stroke (Klohs et al., 2009). In order to overcome
the low sensitivity of FPs to label stem cells before transplanta-
tion, the new class of 2–8 nm small ﬂuorescent quantum dots
(QDs) holds great promise to overcome the low sensitivity of FPs
to label cells. QDs provide surpassing absorbance, highQY,narrow
emission bands and high resistance to photobleaching (Frangioni,
2003; Michalet et al., 2005). Sugiyama et al. (2011) could show that
bone marrow stromal cells, labeled with QDs for the NIR, can be
detected non-invasively up to 8 weeks after transplantation in the
rat brain.
FIGURE 3 | In vivo FLI of thromboembolic-stroke. Fibrin deposition is
visualized with a near-infrared probe against the activated coagulation factor
XIII (FXIIIa; A15) in a thromboembolic model of stroke. Scale bar 5 mm.
Images adapted with permission from Zhang et al. (2012).
FLUORESCENCE NEUROIMAGING AT THE MICRO- AND MACROSCALE
Two-photon microscopy (2PM) is the method of choice to obtain
detailed structural information of neural tissue in vivo [also
referred to 2P laser scanning microscopy (2PLSM)]. A pulsed
infrared laser is used to excite ﬂuorophores by the combined
power of two long-wavelength photons (Sigler andMurphy, 2010),
which promotes better sample penetration, higher resolution, less
light scatter, and less photo-damage compared to in vivo confo-
cal microscopy (Belluscio, 2005). 2PM has also been applied to
freely moving animals equipped with a ﬁber-based endoscopic
system (Helmchen et al., 2001). Using 2PM implies the limita-
tion to the ﬁrst cortical layers within the mouse brain, imaging
subcortical structures requires a cranial window (Dombeck et al.,
2010; Shih et al., 2012). Fluorophores are essential for 2PM,
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either by injectable tracers, like intravenous bolus injection of
ﬂuorescein-conjugated dextran to target blood vessels and blood
ﬂow (Shih et al., 2012), or FPs expressed by speciﬁc cell types
(Belluscio, 2005). Label-free 2PM of the living mouse brain has
been reported by Witte et al. (2011) by using intrinsic non-linear
light interactions, referred to second- and third-harmonic gen-
eration, which can be applied to visualize, e.g., myelin (Farrar
et al., 2011). Zhang and Murphy (2007) and Sigler and Murphy
(2010) could identify with 2PM to which extent reduced blood
ﬂow in stroke leads to changes in synaptic circuitry. Recently,
three-photon microscopy (3PM) extended the depth resolution
to 1 mm by using longer wavelengths (1,700 nm, equivalent to a
one-photon excitation of ∼560 nm), which are less attenuated by
tissue and appropriate to excite a variety of existing ﬂuorophores
(Horton et al., 2013).
A common way to measure neuronal activity indirectly in vivo
is functional magnetic resonance imaging (MRI) on the basis of
the hemodynamic response, thus the locally dynamic changes
in oxy- and deoxyhemoglobin (HbO2 and HbR). Differences in
absorption of HbO2 and HbR can be used by intrinsic imaging
to record cortical activity on a sub-second time scale based on
the changes in blood oxygenation (Ts’o et al., 1990). The exposed
cortex is illuminated sequentially by light of different wavelengths
(multi-spectral reﬂectance imaging). Images are recorded which
are particularly sensitive to changes in HbO2 and HbR concen-
tration. At wavelengths where HbO2 and HbR absorption is the
same (isosbestic points), changes in total hemoglobin concentra-
tion canbemeasured (Hillman,2007). Abookasis et al. (2009) used
NIR illumination in ischemic rat barrel cortex to generate maps of
light absorption, scattering properties and tissue hemoglobin con-
centration. Dynamic changes in cerebral blood ﬂow are acquired
by laser speckle-ﬂow imaging, which is using a similar set-up to
intrinsic imaging but with a laser diode as light source. The laser
speckle pattern is caused by the coherent laser light scattering
within the brain, which is dependent on the movement of red
blood cells over time (Hillman, 2007). A cranial imaging win-
dow is necessary for repeated light illumination of the exposed
cortex (Armitage et al., 2010). Both systems can be combined for
simultaneous blood oxygenation and ﬂow imaging during stroke
in rats (Steimers et al., 2011). However, blood ﬂow dynamics and
neuronal structures are still best resolved with 2PLSM (Shih et al.,
2012).
Grinvald and colleagues paved the way for a direct method to
optically record neuronal activity: voltage sensitive-dyes (VSDs;
Orbach et al., 1985) and voltage sensitive-proteins (VSFPs; Sakai
et al., 2001). Both, VSDs and VSFPs respond to changes in trans-
membrane voltage in the millisecond time scale, by changing
their ﬂuorescence properties [but resolving single action poten-
tials is still limited (Akemann et al., 2009)]. Several studies have
recently applied VSDs on experimental models of stroke to
image functional reorganization of forelimb cortex areas (Brown
et al., 2009; Figure 4A) and long-lasting impairments on the
processing of sensory stimuli by the forelimb somatosensory
cortex (Sweetnam and Brown, 2013). Weerakkody et al. (2013)
applied VSD imaging to study the cortical activity after implan-
tation of NSCs into the ventricle of naïve mice. They found
that high-density engraftment of non-integrating NSCs leads
to functional defects in cortical layers (Weerakkody et al., 2013;
Figure 4B).
BIOLUMINESCENCE IMAGING
In vivo BLI uses, similar to ﬂuorescence imaging (FLI), a CCD
camera housed in a light-tight chamber to collect photon emission
from the anesthetized animal. But instead of an excitation source,
photons are emitted when the intracellular enzyme luciferase oxi-
dizes its substrate luciferin. As luciferase is only expressed in trans-
genic mammalian cells, there is only negligible BLI background
signal and emitted photons can be detected with surpassing sensi-
tivity through the intact skull (Keyaerts et al., 2012a) – even from
freely moving awake animals (Keyaerts et al., 2012b). BLI is a high
throughput technique, scalable from in vitro to in vivo, highly
non-invasive and ease of use. Similar to FLI, the spatial reso-
lution is limited to several mm (Massoud and Gambhir, 2003).
Although the number of photons emitted is proportional to the
number of luciferase molecules (De Wet et al., 1987), quantiﬁca-
tion of in vivo BLI is also challenged by biological factors (e.g.,
substrate bio-distribution, luciferase expression, stability, and
inhibition) and physical factors (e.g., emission wavelength, light
attenuation by overlying tissue; Keyaerts et al., 2012a). The per-
centage of transmitted light is linearly decreasing with depth of
the bioluminescent source in the rodent brain (Pesnel et al., 2011).
However, this could be used to predict the extent of optical atten-
uation for correct quantiﬁcation (Virostko and Jansen, 2009). BLI
quantiﬁcation in vitro relies on excess conditions of ATP and oxy-
gen. But in vivo only 5% of the systemic administered luciferin
reaches the brain (Berger et al., 2008), as it has to pass several
biological barriers to reach the cell of interest and distribution
is dependent on the hemodynamic rate (Keyaerts et al., 2012a).
Luciferin can pass freely through the BBB, but efﬂux transporters
like ABCG2 actively pump it back to the lumen (Bakhsheshian
et al., 2013) and BBB disruption during stroke may affect biodis-
tribution. Recently, luciferin derivates have been developed to
boost sensitivity especially for the mouse brain even at lower doses
(Evans et al., 2014). In addition, we proposed an optimized neu-
roimaging protocol, which minimizes inhibitory effects on the
luciferase-luciferin reaction while maximizing the photon detec-
tion by a factor of two over conventional experimental protocols
and provides detection of 3,000 NSCs in vivo (Aswendt et al., 2013;
Figure 5A).
LUCIFERASES FOR IN VIVO IMAGING
Luciferase enzymes occur naturally in numerous luminous species,
such as the North American ﬁreﬂy [ﬁreﬂy luciferase (Fluc)],
click beetles [click beetle luciferase (CBR)], the sea pansy Renilla
reniformis [Renilla luciferase (Rluc)], and the copepod Gaus-
sia princeps [Gaussia luciferase (Gluc); Mezzanotte et al., 2013].
There are species-speciﬁc changes in the substrate, co-factors
and emitted wavelength. Gluc and Rluc emit in the blue spec-
trum and therefore are not optimal for in vivo use, as it gets
strongly absorbed when traveling through tissue (see Figure 1).
Fluc and CBR, on the other hand, have a strong component
above 600 nm (Figure 6) resulting in less absorption (Zhao et al.,
2005). Changes in one single amino acid of the luciferase can
already result in wavelength shifts. Extensive mutagenesis was
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FIGURE 4 |VSD imaging detects macroscopic changes in functional
networks after stroke and implantation of NSCs. (A) Changes of the
functional representation of the forelimb (FL) cortex area toward the
peri-infarct primary motor cortex M1 and hindlimb (HL) area appear
8 weeks upon photothrombotic stroke but not sham surgery. Reprinted
by permission from MacMillan Publisher Ltd: Molecular Therapy (Brown
et al., 2009). (B) With increasing number of cortical grafts (confocal
images upper row), the amplitude of cortical activation is reduced as
displayed in color-coded maps (lower row) of cortical activation depicting
the maximum of mean ﬂuorescence intensity change (F/F0) within
1024 ms recording interval. Images adapted with permission from
Weerakkody et al. (2013).
FIGURE 5 | In vivo monitoring of endogenous and implanted stem cells.
(A)The improved BLI protocol (300 mg/kg Luciferin pre Isoﬂuran anaesthesia)
promotes substantial higher photon emission compared to standard protocol
(150 mg/kg Luciferin post anesthesia) and the lowers the detection limit to
3,000 engrafted NSCs in vivo. Signal-to-noise ratio (SNR) above 3 was deﬁned
as a limit for reliable cell graft detection. (B) Bioluminescence images of a
1 day and 2 month old doublecortin-luciferase mouse for in vivo imaging of
endogenous neurogenesis (Insert shows neurogenesis in the spinal cord and
the olfactory bulbs, respectively). Images modiﬁed with permission from
Aswendt et al. (2013) and Couillard-Despres et al. (2008).
performed to create red andgreen shifts and improvepH-tolerance
and thermostability (Miloud et al., 2011; Jathoul et al., 2012). To
answer the question, which luciferase ﬁts best the brain appli-
cation, we recently evaluated the codon-optimized Luc2, the
red codon-optimized mutant PpyRE9 (Liang et al., 2012), the
codon-optimized hRluc and the green CBG99. BLI signal from
transduced cells in vivo after intracerebral transplantation showed
photon emission decrease in the order of Luc2, CBG99, PpyRE9
to hRluc (Mezzanotte et al., 2013). Most importantly, as the
green part of emission spectra gets strongly absorbed, luciferases
with a high QY and red-shifted emission are preferable. Multi-
color BLI, e.g., to distinguish two cell types becomes possible by
combining Luc2/hRluc [through the not cross-reacting substrates
luciferin and coelenterazine (Bhaumik and Gambhir, 2002)] or
CBG99/PpyRE9 [through spectral unmixing of the green and red
emission light (Mezzanotte et al., 2013)].
BIOLUMINE SCENE IMAGING OF ENDOGENOUS AND EXOGENOUS
STEM CELLS FOR STROKE REPAIR
Stem cell therapy has already been proven beneﬁcial for stroke
recovery (Bliss et al., 2007; Oki et al., 2012), however, the mecha-
nisms of action needs further investigation. BLI provides unique
information about the dynamics of NSCs, such as location,
migration and proliferation. Exogenous stem cells have to be
transgenically modiﬁed to express a luciferase protein in order
to allow longitudinal in vivo optical imaging after implantation.
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FIGURE 6 | In vivo emission spectra of bioluminescent reporters.
Emission spectra from luciferase expression in skin, lung, and liver are
compared with those from labeled cells in culture showing tissue-induced
light attenuation in the blue spectrum. Photon ﬂuxes are normalized to
the values at 680 nm for beetle luciferases and 640 nm for Renilla
luciferase (indicated at green arrow), where absorption is minimal.
Hemoglobin absorption curves are plotted as background (shaded in gray).
hRLuc, Renilla reniformis; CBGr68, click beetle green; CBRed, click beetle
red; Fluc+, Fireﬂy luciferase. Reproduced with permission from Zhao et al.
(2005).
By using bicistronic vectors for expression of two transgenes, e.g.,
a bioluminescent reporter for in vivo BLI together with a ﬂuores-
cent reporter (e.g., EGFP) provides the opportunity to also detect
engrafted cells by invasive methods such as histology, microscopy,
RT-PCR and Western blot. Notably, some luciferases, as Fluc,
are dependent on ATP, thus serving as a non-invasive viability
marker of engrafted stem cells to assess survival in vivo. Using
this biochemical relationship Boehm-Sturm et al. (2014) inves-
tigated whether the peri-infarct region is a location permissive
for stem cell survival. Their multimodal approach of 19F-MRI
and BLI revealed that human NSCs after intracerebral implanta-
tion into the peri-infarct region show same survival behavior as
when implanted into healthy brain tissue. In vivo BLI has also
been used to assess the recruitment of NSCs in stroke mice after
contralateral parenchymal, intra-ventricular (Kim et al., 2004) or
intra-arterial injection (Rosenblum et al., 2012). Murin neural
precursor transfected to express Fluc showed strong migrational
activity toward the lesioned hemisphere when transplanted con-
tralaterally. Despite the rather poor spectral resolution of BLI
compared to other imaging modalities like MRI, Kim et al. (2004)
could detect the midline crossing as early as 7 days after graft-
ing (Quattromani et al., 2014). Also intraventricular injection
of this cell line into stroke mice resulted in strong recruitment
to the lesioned area (Quattromani et al., 2014). Intra-arterially
injected murine neural progenitors transduced to express Gluc
were found to reach the brain, with largest recruitment to the
brain when injected 3 days after hypoxia-ischemia (Cordeau et al.,
2008).
The second source of stem cells for stroke repair is the pool
of endogenous stem cells, e.g., within the subventricular zone.
These cells can be either targeted by in vivo transduction with a
viral vector to express Fluc (Reumers et al., 2008), or by design-
ing a neural progenitor-speciﬁc reporter mouse, in which Fluc
expression is controlled by the doublecortin (DCX) promotor
(Couillard-Despres et al., 2008). Both approaches allow quantita-
tive observation of adult neurogenesis (Figure 5B) and represent
useful non-invasive tools to investigate the therapeutic potential
of endogenous stem cells for stroke recovery. Using conditional
viral vectors, Vandeputte et al. (2014) labeled Nestin-positive cells
of the subventricular zone prior to induction of photothrombotic
stroke and followed the recruitment to the lesion for 90 days.
Photothrombotic stroke is a variation of ischemic stroke models,
which produces localized cortical strokes based on microvascular
thrombosis after localized photosensitive dye activation. Already
2 days after stroke, the number of endogenous neural progeni-
tor cells increased and translocated to the lesion site, peaking at
14 days and declining thereafter (Vandeputte et al., 2014). The time
proﬁle of the endogenous neural progenitor cell proliferation in
response to ischemic stroke of the middle cerebral artery territory
was investigatedusing theDCXreportermousemodel (Adamczak,
2013). A similar early rise in proliferation was observed within
the ﬁrst week. Other aspects of neural replacement have been
investigated by non-invasive BLI. For example neural responses
to stroke by Gravel et al. (2011) using a multimodal transgenic
mouse targeting the growth associated protein GAP-43. BLI could
show that the nervous tissue-speciﬁc GAP-43 is silent in adult
neurons, but up-regulated after neural injury and contributes
to neurite outgrowth as part of the regeneration process after
stroke. Post-stroke neurogenesis is effected by the inﬂammatory
response (Kokaia et al., 2012), which can be monitored with a
transgenic mouse model expressing Fluc under the control of the
toll-like receptor (TLR) two promotor (Lalancette-Hébert et al.,
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2009). TLRs are expressed by cells of the innate immune sys-
tem to identify damage-associated patterns released during cell
damage. Quattromani et al. (2014) successfully used this mouse
model to visualize that the inﬂammatory response in stroke mice
is decreased when the animals had access to enriched environ-
ment in their cages. The inﬂammation post stroke was also found
to be sex dependent using a transgenic mouse model with Fluc
restricted to GFAP positive cells, predominantly astrocytes. While
male mice showed a correlation of astrogliosis and infarct volume,
such a correlation was missing in female mice (Cordeau et al.,
2008).
FUTURE DIRECTIONS
CELL FATE IMAGING
Besides the possibility to track the viability of transplanted NSCs
by BLI, luciferases have been linked to neural cell speciﬁc pro-
moters to monitor differentiation. Such system was successfully
used to trace the in vivo activation of neuronal differentiation
by coupling Fluc to the NeuroD promoter which is active in neu-
ronal precursor cells (Oh et al., 2013). Weak cell speciﬁc promoters
can be enhanced by coupling them to a two-step transcriptional
ampliﬁcation (TSTA; Hwang do et al., 2008). An efﬁcient in vitro
method to increase reliability of BLI quantiﬁcation was described
as dual-reporter systems, which uses a constitutive promoter to
image the localization, viability and quantity of transplanted cells
and a cell speciﬁc promoter to monitor the differentiation degree
in real-time based on two different luciferases (Kern et al., 2013;
Xu et al., 2014). The dual-reporter system can be used to answer
important questions, such as (i) the optimal type and number of
NSCs to be administered, (ii) the route of administration, and (iii)
the best time to administer cells after injury with higher accuracy
compared to single reporter assays.
COMBINATION OF NON-INVASIVE IMAGING TECHNIQUES
Optical imaging provides best sensitivity of 10−15–10−17 mol/l
for visualization of stem cell therapy in stroke (Massoud and
Gambhir, 2003). Among many recent technical developments,
optoacoustic (photoacoustic) imaging holds great potential to
visualize both, the stem cell graft location (Jokerst et al., 2012)
and progression/reorganization of the stroke lesion (Kneipp et al.,
2014) with one non-invasive imaging device. However, also the
combination of optical imaging with other non-invasive imag-
ing techniques like positron emission tomography (PET) and
MRI is of interest, as complementary functional and structural
information can be derived. A novel multimodal approach is the
combination of PET and optical intrinsic imaging to character-
ize cortical spreading depression in ischemic rats (Gramer et al.,
2014). PET imaging may also be useful to quantify the metabolic
rate (via the glucose consumption) and oxygen distribution, two
important factors in stroke pathology, and confounding factors
for BLI. Another multimodal approach is the combination of
MRI with BLI to characterize transplanted NSCs in the stroke
pathology. Fireﬂy bioluminescence was used as a viability marker
while transplant location was visualized with iron oxide label-
ing by MRI for 8 weeks (Daadi et al., 2009). Sequential MRI/BLI
was successfully employed to investigate the amount and distribu-
tion of intra-arterially (i.a.) versus intra-venously (i.v.) injected
stem cells in an ischemia model, showing brain accumulation
after i.a. but not after i.v. injection (Pendharkar et al., 2010).
We have combined the advanced 19F MRI technique for unam-
biguous graft location on high-resolution structural MR images
with BLI for monitoring cell viability (Boehm-Sturm et al., 2014).
There, the murine NSCs were transplanted next to the stroke
lesion in nude mice. But the graft location had no effect on the
decline in cell survival over 14 days observation period. Further
technical developments are needed to improve sensitivity, spatial
resolution and integration of imaging techniques to facilitate co-
registration of quantitative data (e.g., on database references as
the Allen brain atlas, http://www.brain-map.org/). The combina-
tion of optical imaging with MRI data could be used to create
3D reconstructions to relocate cell function back to the anatom-
ical structure, which is highly resolved by MRI (100 μm spatial
resolution).
We believe that the application of the non-invasive imag-
ing tools presented here will be essential to fully understand
stroke regeneration and the potential of engrafted stem cells in
pre-clinical trials – the prerequisite of an effective clinical therapy.
AUTHOR CONTRIBUTIONS
Markus Aswendt, Joanna Adamczak and Annette Tennstaedt
wrote the manuscript.
ACKNOWLEDGMENTS
We thank Markus Gramer (MPI) for comments on parts of the
manuscript. This work was ﬁnancially supported by the EU-FP7
program TargetBraIn (HEALTH-F2-2012-279017) and Brainpath
(PIAPP-GA-2013-612360).
REFERENCES
Abookasis, D., Lay, C. C., Mathews, M. S., Linskey, M. E., Frostig, R. D., and
Tromberg, B. J (2009). Imaging cortical absorption, scattering, and hemody-
namic response during ischemic stroke using spatially modulated near-infrared
illumination. J. Biomed. Opt. 14, 024033. doi: 10.1117/1.3116709
Adamczak, J. (2013). Watching the Healing Brain: Multimodal and Non-invasive
Imaging of Regenerative Processes after Experimental Cerebral Ischemia. Ph.D.
thesis, Faculty of Mathematics and Natural Sciences, University of Cologne,
Cologne.
Akemann, W., Middleton, S. J., and Knöpfel, T. (2009). Optical imaging as a link
between cellular neurophysiology and circuit modeling. Front. Cell. Neurosci. 3:5.
doi: 10.3389/neuro.03.005.2009
Armitage, G. A., Todd, K. G., Shuaib, A., and Winship, I. R. (2010). Laser speckle
contrast imaging of collateral blood ﬂow during acute ischemic stroke. J. Cereb.
Blood Flow Metab. 30, 1432–1436. doi: 10.1038/jcbfm.2010.73
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal
replacement from endogenous precursors in the adult brain after stroke. Nat.
Med. 8, 963–970. doi: 10.1038/nm747
Aswendt, M., Adamczak, J., Couillard-Despres, S., and Hoehn, M. (2013). Boosting
bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS
ONE 8:e55662. doi: 10.1371/journal.pone.0055662
Bahmani, P., Schellenberger, E., Klohs, J., Steinbrink, J., Cordell, R., Zille, M., et al.
(2011). Visualization of cell death in mice with focal cerebral ischemia using
ﬂuorescent annexin A5, propidium iodide, and TUNEL staining. J. Cereb. Blood
Flow Metab. 31, 1311–1320. doi: 10.1038/jcbfm.2010.233
Bakhsheshian, J., Wei, B. R., Chang, K. E., Shukla, S., Ambudkar, S. V., Simpson,
R. M., et al. (2013). Bioluminescent imaging of drug efﬂux at the blood–brain
barrier mediated by the transporter ABCG2. Proc. Natl. Acad. Sci. U.S.A. 110,
20801–20806. doi: 10.1073/pnas.1312159110
Belluscio, L. (2005). Two-photon imaging in live rodents. Curr. Protoc. Neurosci.
Chap. 2, Unit 2.9. doi: 10.1002/0471142301.ns0209s32
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 226 | 7
Aswendt et al. Optical neuroimaging in stroke therapy
Berger, F., Paulmurugan, R., Bhaumik, S., and Gambhir, S. S. (2008). Uptake kinetics
and biodistribution of 14C-D-luciferin–a radiolabeled substrate for the ﬁreﬂy
luciferase catalyzed bioluminescence reaction: impact on bioluminescence based
reporter gene imaging. Eur. J. Nucl. Med. Mol. Imaging 35, 2275–2285. doi:
10.1007/s00259-008-0870-6
Bhaumik, S., and Gambhir, S. S. (2002). Optical imaging of Renilla luciferase
reporter gene expression in living mice. Proc. Natl. Acad. Sci. U.S.A. 99, 377–382.
doi: 10.1073/pnas.012611099
Bihel, E., Pro-Sistiaga, P., Letourneur, A., Toutain, J., Saulnier, R., Insausti,
R., et al. (2010). Permanent or transient chronic ischemic stroke in the
non-human primate: behavioral, neuroimaging, histological, and immuno-
histochemical investigations. J. Cereb. Blood Flow Metab. 30, 273–285. doi:
10.1038/jcbfm.2009.209
Bliss, T., Guzman, R., Daadi, M., and Steinberg, G. K., (2007). Cell transplanta-
tion therapy for stroke. Stroke 38, 817–826. doi: 10.1161/01.STR.0000247888.
25985.62
Boehm-Sturm, P., Aswendt, M., Minassian, A., Michalk, S., Mengler, L., Adamczak,
J., et al. (2014). A multi-modality platform to image stem cell graft survival in
the naïve and stroke-damaged mouse brain. Biomaterials 35, 2218–2226. doi:
10.1016/j.biomaterials.2013.11.085
Brown, C. E., Aminoltejari, K., Erb, H., Winship, I. R., and Murphy, T. H. (2009).
In vivo voltage-sensitive dye imaging in adult mice reveals that somatosensory
maps lost to stroke are replaced over weeks by new structural and functional
circuits with prolonged modes of activation within both the peri-infarct zone
and distant sites. J. Neurosci. 29, 1719–1734. doi: 10.1523/JNEUROSCI.4249-
08.2009
Cai,D., Cohen,K. B., Luo, T., Lichtman, J.W., and Sanes, J. R. (2013). Improved tools
for the Brainbow toolbox. Nat. Methods 10, 540–547. doi: 10.1038/nmeth.2450
Chalﬁe, M., Tu, Y., Euskirchen, G., Ward, W. W., and Prasher, D. C. (1994). Green
ﬂuorescent protein as a marker for gene expression. Science 263, 802–805. doi:
10.1126/science.8303295
Cheong, W. F. F., Prahl, S. A., and Welch, A. J. (1990). A review of the optical
properties of biological tissues. IEEE J. Quantum Electron. 26, 2166–2185. doi:
10.1109/3.64354
Chudakov,D.M.,Matz,M.V., Lukyanov, S., and Lukyanov,K.A. (2010). Fluorescent
proteins and their applications in imaging living cells and tissues. Physiol. Rev.
90, 1103–1163. doi: 10.1152/physrev.00038.2009
Cordeau, P. Jr., Lalancette-Hébert, M.,Weng, Y. C., and Kriz, J. (2008). Live imaging
of neuroinﬂammation reveals sex and estrogen effects on astrocyte response to
ischemic injury. Stroke 39, 935–942. doi: 10.1161/STROKEAHA.107.501460
Couillard-Despres, S., Finkl, R., Winner, B., Ploetz, S., Wiedermann, D., Aigner, R.,
et al. (2008). In vivo optical imaging of neurogenesis: watching new neurons in
the intact brain. Mol. Imaging 7, 28–34.
Daadi, M. M., Li, Z., Arac, A., Grueter, B. A., Soﬁlos, M., Malenka, R. C., et al.
(2009). Molecular and magnetic resonance imaging of human embryonic stem
cell-derivedneural stemcell grafts in ischemic rat brain.Mol.Ther. 17, 1282–1291.
doi: 10.1038/mt.2009.104
De Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., and Subramani, S. (1987).
Fireﬂy luciferase gene: structure and expression in mammalian cells. Mol. Cell.
Biol. 7, 725–737.
Deliolanis, N. C., and Ntziachristos, V. (2013). Fluorescence molecular tomogra-
phy of brain tumors in mice. Cold Spring Harb. Protoc. 2013, 438–443. doi:
10.1101/pdb.prot074245
Dombeck, D. A., Harvey, C. D., Tian, L., Looger, L. L., and Tank, D. W. (2010).
Functional imagingof hippocampal place cells at cellular resolutionduring virtual
navigation. Nat. Neurosci. 13, 1433–1440. doi: 10.1038/nn.2648
Eaton, V. L., Vasquez, K. O., Goings, G. E., Hunter, Z. N., Peterson, J. D., and
Miller, S. D. (2013). Optical tomographic imaging of near infrared imaging agents
quantiﬁes disease severity and immunomodulation of experimental autoimmune
encephalomyelitis in vivo. J. Neuroinﬂammation 10, 138. doi: 10.1186/1742-2094-
10-138
Evans, M. S., Chaurette, J. P., Adams, S. T. Jr., Reddy, G. R., Paley, M. A., Aronin,
N., et al. (2014). A synthetic luciferin improves bioluminescence imaging in live
mice. Nat. Methods 11, 393–395. doi: 10.1038/nmeth.2839
Farrar, M. J., Wise, F. W., Fetcho, J. R., and Schaffer, C. B. (2011). In vivo imag-
ing of myelin in the vertebrate central nervous system using third harmonic
generation microscopy. Biophys. J. 100, 1362–1371. doi: 10.1016/j.bpj.2011.
01.031
Frangioni, J. V. (2003). In vivo near-infrared ﬂuorescence imaging. Curr. Opin.
Chem. Biol. 7, 626–634. doi: 10.1016/j.cbpa.2003.08.007
Gramer, M., Feuerstein, D., Steimers, A., Takagaki, M., Kumagai, T., Sué, M.,
et al. (2014). Device for simultaneous positron emission tomography, laser
speckle imaging and RGB reﬂectometry: validation and application to cortical
spreading depression and brain ischemia in rats. Neuroimage 94C, 250–262. doi:
10.1016/j.neuroimage.2014.03.027
Gravel, M., Weng, Y. C., and Kriz, J. (2011). Model system for live imaging of
neuronal responses to injury and repair. Mol. Imaging 10, 434–445.
Helmchen, F., Fee, M. S., Tank, D. W., and Denk, W. (2001). A minia-
ture head-mounted two-photon microscope. high-resolution brain imaging
in freely moving animals. Neuron 31, 903–912. doi: 10.1016/S0896-6273(01)
00421-4
Hillman, E. M. C. (2007). Optical brain imaging in vivo: techniques and appli-
cations from animal to man. J. Biomed. Opt. 12, 051402. doi: 10.1117/1.
2789693
Horton, N. G., Wang, K., Kobat, D., Clark, C. G., Wise, F. W., Schaffer, C. B., et al.
(2013). In vivo three-photonmicroscopy of subcortical structureswithin an intact
mouse brain. Nat. Photonics 7, 205–209. doi: 10.1038/nphoton.2012.336
Hwang do,W., Kang, J. H., Jeong, J.M., Chung, J. K., Lee,M.C., Kim, S., et al. (2008).
Noninvasive in vivo monitoring of neuronal differentiation using reporter driven
by a neuronal promoter. Eur. J. Nucl. Med. Mol. Imaging 35, 135–145. doi:
10.1007/s00259-007-0561-8
Iadecola, C., and Anrather, J. (2011). Stroke research at a crossroad: asking the brain
for directions. Nat. Neurosci. 14, 1363–1368. doi: 10.1038/nn.2953
Jablonska, A., Kozlowska, H., Markiewicz, I., Domanska-Janik, K., and Lukom-
ska, B. (2010). Transplantation of neural stem cells derived from human cord
blood to the brain of adult and neonatal rats. Acta Neurobiol. Exp. (Wars). 70,
337–350.
Jathoul, A., Law, E., Gandelman, O., Pule, M., Tisi, L., and Murray, J. (2012). “Devel-
opment of a pH-tolerant thermostable photinus pyralis luciferase for brighter in
vivo imaging,” in Bioluminescence - Recent Advances in Oceanic Measurements and
Laboratory Applications, ed. D. Lapota (Rijeka: InTech).
Jokerst, J. V., Thangaraj, M., Kempen, P. J., Sinclair, R., and Gambhir, S. S. (2012).
Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated
gold nanorods. ACS Nano 6, 5920–5930. doi: 10.1021/nn302042y
Kern, I., Xu, R., Julien, S., Suter, D. M., Preynat-Seauve, O., Baquié, M., et al. (2013).
Embryonic stem cell-based screen for small molecules: cluster analysis reveals
four response patterns in developing neural cells. Curr. Med. Chem. 20, 710–723.
doi: 10.2174/092986713804999330
Keyaerts, M., Caveliers, V., and Lahoutte, T. (2012a). Bioluminescence imag-
ing: looking beyond the light. Trends Mol. Med. 18, 164–172. doi:
10.1016/j.molmed.2012.01.005
Keyaerts, M., Remory, I., Caveliers, V., Breckpot, K., Bos, T. J., Poelaert, J.,
et al. (2012b). Inhibition of ﬁreﬂy luciferase by general anesthetics: effect
on in vitro and in vivo bioluminescence imaging. PLoS ONE 7:e30061. doi:
10.1371/journal.pone.0030061
Kim, D. E., Schellingerhout, D., Ishii, K., Shah, K., and Weissleder,
R. (2004). Imaging of stem cell recruitment to ischemic infarcts in
a murine model. Stroke 35, 952–957. doi: 10.1161/01.STR.0000120308.
21946.5D
Klohs, J., Baeva, N., Steinbrink, J., Bourayou, R., Boettcher, C., Royl, G., et al.
(2009). In vivo near-infrared ﬂuorescence imaging of matrix metalloproteinase
activity after cerebral ischemia. J. Cereb. Blood Flow Metab. 29, 1284–1292. doi:
10.1038/jcbfm.2009.51
Klohs, J., Gräfe, M., Graf, K., Steinbrink, J., Dietrich, T., Stibenz, D.,
et al. (2008). In vivo imaging of the inﬂammatory receptor CD40 after
cerebral ischemia using a ﬂuorescent antibody. Stroke 39, 2845–2852. doi:
10.1161/STROKEAHA.107.509844
Klohs, J., Steinbrink, J., Nierhaus, T., Bourayou, R., Lindauer, U., Bahmani, P., et al.
(2006). Noninvasive near-infrared imaging of ﬂuorochromes within the brain of
live mice: an in vivo phantom study. Mol. Imaging 5, 180–187.
Kneipp, M., Turner, J., Hambauer, S., Krieg, S. M., Lehmberg, J., Lindauer, U.,
et al. (2014). Functional real-time optoacoustic imaging of middle cerebral artery
occlusion in mice. PLoS ONE 9:e96118. doi: 10.1371/journal.pone.0096118
Kokaia, Z., Martino, G., Schwartz, M., and Lindvall, O. (2012). Cross-talk between
neural stem cells and immune cells: the key to better brain repair? Nat. Neurosci.
15, 1078–1087. doi: 10.1038/nn.3163
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 226 | 8
Aswendt et al. Optical neuroimaging in stroke therapy
Lalancette-Hébert, M., Phaneuf, D., Soucy, G., Weng, Y. C., and Kriz, J. (2009).
Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role
of olfactory bulb microglia as modulators of inﬂammation. Brain 132, 940–954.
doi: 10.1093/brain/awn345
Liang, Y., Walczak, P., and Bulte, J. W. (2012). Comparison of red-shifted ﬁreﬂy
luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter
genes for in vivo imaging of stem cells. J. Biomed. Opt. 17, 016004. doi:
10.1117/1.JBO.17.1.016004
Mäkinen, M., Joki, T., Ylä-Outinen, L., Skottman, H., Narkilahti, S., and
Aänismaa, R. (2013). Fluorescent probes as a tool for cell population track-
ing in spontaneously active neural networks derived from human pluripotent
stem cells. J. Neurosci. Methods 215, 88–96. doi: 10.1016/j.jneumeth.2013.
02.019
Massoud, T. F., and Gambhir, S. S. (2003). Molecular imaging in living subjects:
seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580.
doi: 10.1101/gad.1047403
Massoud, T. F., Singh, A., and Gambhir, S. S. (2008a). Noninvasive molecular
neuroimaging using reporter genes: part I, principles revisited. AJNR Am. J.
Neuroradiol. 29, 229–234. doi: 10.3174/ajnr.A0864
Massoud, T. F., Singh, A., and Gambhir, S. S. (2008b). Noninvasive molec-
ular neuroimaging using reporter genes: part II, experimental, current, and
future applications. AJNR Am. J. Neuroradiol. 29, 409–418. doi: 10.3174/
ajnr.A0863
Mezzanotte, L., Aswendt, M., Tennstaedt, A., Hoeben, R., Hoehn, M., and Löwik,
C. (2013). Evaluating reporter genes of different luciferases for optimized in vivo
bioluminescence imaging of transplanted neural stem cells in the brain. Contrast
Media Mol. Imaging 8, 505–513. doi: 10.1002/cmmi.1549
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., et al.
(2005). Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307,
538–544. doi: 10.1126/science.1104274
Miloud, T., Henrich, C., and Hämmerling, G. J. (2011). Quantitative comparison of
click beetle and ﬁreﬂy luciferases for in vivo bioluminescence imaging. J. Biomed.
Opt. 12, 054018. doi: 10.1117/1.2800386
Oh, H. J., Hwang do, W., Youn, H., and Lee, D. S. (2013). In vivo biolumi-
nescence reporter gene imaging for the activation of neuronal differentiation
induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor
cells. Eur. J. Nucl. Med. Mol. Imaging 40, 1607–1617. doi: 10.1007/s00259-013-
2457-0
Oki, K., Tatarishvili, J., Wood, J., Koch, P., Wattananit, S., Mine, Y., et al. (2012).
Human-induced pluripotent stem cells form functional neurons and improve
recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120–1133. doi:
10.1002/stem.1104
Orbach, H. S., Cohen, L. B., and Grinvald, A. (1985). Optical mapping of electrical
activity in rat somatosensory and visual cortex. J. Neurosci. 5, 1886–1895.
Palmer, K. F., and Williams, D. (1974). Optical properties of water in the near
infrared. J. Opt. Soc. Am. 64, 1107. doi: 10.1364/JOSA.64.001107
Pendharkar, A. V., Chua, J. Y., Andres, R. H., Wang, N., Gaeta, X., Wang, H.,
et al. (2010). Biodistribution of neural stem cells after intravascular therapy
for hypoxic-ischemia. Stroke 41, 2064–2070. doi: 10.1161/STROKEAHA.109.
575993
Pesnel, S., Pillon, A., Créancier, L., Guilbaud, N., Bailly, C., Kruczynski, A.,
et al. (2011). Quantitation in bioluminescence imaging by correction of tis-
sue absorption for experimental oncology. Mol. Imag. Biol. 13, 646–652. doi:
10.1007/s11307-010-0387-9
Pope, R. M., and Fry, E. S. (1997). Absorption spectrum (380–700 nm) of pure
water. II. Integrating cavity measurements. Appl. Opt. 36, 8710–8723. doi:
10.1364/AO.36.008710
Prahl, S. (1999). Optical Absorption of Hemoglobin. Available at: http://omlc.org/
spectra/hemoglobin/ [accessed December 15, 1999].
Quattromani, M. J., Cordeau, P., Ruscher, K., Kriz, J., and Wieloch, T.
(2014). Enriched housing down-regulates the Toll-like receptor 2 response in
the mouse brain after experimental stroke. Neurobiol. Dis. 66C, 66–73. doi:
10.1016/j.nbd.2014.02.010
Rao, J., Dragulescu-Andrasi, A., and Yao, H. (2007). Fluorescence imag-
ing in vivo: recent advances. Curr. Opin. Biotechnol. 18, 17–25. doi:
10.1016/j.copbio.2007.01.003
Reumers, V., Deroose, C. M., Krylyshkina, O., Nuyts, J., Geraerts, M., Mortelmans,
L., et al. (2008). Noninvasive and quantitative monitoring of adult neuronal stem
cell migration in mouse brain using bioluminescence imaging. Stem Cells 26,
2382–2390. doi: 10.1634/stemcells.2007-1062
Rosenblum, S., Wang, N., Smith, T. N., Pendharkar, A. V., Chua, J. Y., Birk, H., et al.
(2012). Timing of intra-arterial neural stem cell transplantation after hypoxia-
ischemia inﬂuences cell engraftment, survival, and differentiation. Stroke 43,
1624–1631. doi: 10.1161/STROKEAHA.111.637884
Ross, K. F. A. (1967). Phase Contrast and Interference Microscopy for Cell Biologists.
London: Edward Arnold Publishers.
Sakai, R., Repunte-Canonigo, V., Raj, C. D., and Knöpfel, T. (2001).
Design and characterization of a DNA-encoded, voltage-sensitive ﬂuores-
cent protein. Eur. J. Neurosci. 13, 2314–2318. doi: 10.1046/j.0953-816x.2001.
01617.x
Sarna, T., and Swartz, H. A. (2006). “The physical properties of melanins,” in The
Pigmentary System Physiology and Pathophysiology, eds J. J. Nordlund, R. E. Boissy,
V. J. Hearing, R. A. King, W. S. Oetting, and J.-P. Ortonne (Oxford: Blackwell
Publishing), 311–341.
Schulz, R. B., and Semmler, W. (2008). Fundamentals of optical imag-
ing. Handb. Exp. Pharmacol. 85, 3–22. doi: 10.1007/978-3-540-
72718-7_1
Shah, K., and Weissleder, R. (2005). Molecular optical imaging: applications lead-
ing to the development of present day therapeutics. NeuroRx 2, 215–225. doi:
10.1602/neurorx.2.2.215
Shaner, N. C., Steinbach, P. A., and Tsien, R. Y. (2005). A guide to
choosing ﬂuorescent proteins. Nat. Methods 2, 905–909. doi: 10.1038/
nmeth819
Shcherbakova, D. M., and Verkhusha, V. V. (2013). Near-infrared ﬂuorescent
proteins for multicolor in vivo imaging. Nat. Methods 10, 751–754. doi:
10.1038/nmeth.2521
Shih, A. Y., Driscoll, J. D., Drew, P. J., Nishimura, N., Schaffer, C. B., and Kleinfeld, D.
(2012). Two-photon microscopy as a tool to study blood ﬂow and neurovascular
coupling in the rodent brain. J. Cereb. Blood Flow Metab. 32, 1277–1309. doi:
10.1038/jcbfm.2011.196
Sigler, A., and Murphy, T. H. (2010). In vivo 2-photon imaging of ﬁne structure
in the rodent brain: before, during, and after stroke. Stroke 41, S117–S123. doi:
10.1161/STROKEAHA.110.594648
Smith, B. A., Xie, B. W., van Beek, E. R., Que, I., Blankevoort, V., Xiao, S.,
et al. (2012). Multicolor ﬂuorescence imaging of traumatic brain injury in
a cryolesion mouse model. ACS Chem. Neurosci. 3, 530–537. doi: 10.1021/
cn3000197
Steimers, A., Gramer, M., Takagaki, M., Graf, R., and Kohl-Bareis, M. (2011).
Simultaneous imaging of haemoglobin oxygenation and blood ﬂow with RGB
reﬂectometry and LASCA during stroke in rats. Diffuse Optical Imaging III 8088,
808808. doi: 10.1117/12.889438
Sugiyama, T., Kuroda, S., Osanai, T., Shichinohe, H., Kuge, Y., Ito, M., et al. (2011).
Near-infrared ﬂuorescence labeling allows noninvasive tracking of bone marrow
stromal cells transplanted into rat infarct brain. Neurosurgery 68, 1036–1047;
discussion 1047. doi: 10.1227/NEU.0b013e318208f891
Sutton, E. J., Henning, T. D., Pichler, B. J., Bremer, C., and Daldrup-Link, H.
E. (2008). Cell tracking with optical imaging. Eur. Radiol. 18, 2021–2032. doi:
10.1007/s00330-008-0984-z
Sweetnam, D. A., and Brown, C. E. (2013). Stroke induces long-lasting deﬁcits in
the temporal ﬁdelity of sensory processing in the somatosensory cortex. J. Cereb.
Blood Flow Metab. 33, 91–96. doi: 10.1038/jcbfm.2012.135
Ts’o, D. Y., Frostig, R. D., Lieke, E. E., and Grinvald, A. (1990). Functional organiza-
tion of primate visual cortex revealed by high resolution optical imaging. Science
249, 417–420. doi: 10.1126/science.2165630
Vandeputte, C., Reumers, V., Aelvoet, S. A., Thiry, I., De Swaef, S., Van den Haute,
C., et al. (2014). Bioluminescence imaging of stroke-induced endogenous neural
stem cell response. Neurobiol. Dis. 69, 144–155. doi: 10.1016/j.nbd.2014.05.014
Virostko, J., and Jansen, E. D. (2009). Validation of bioluminescent imaging
techniques. Methods Mol. Biol. 574, 15–23. doi: 10.1007/978-1-60327-321-3_2
Walcott, B. P., and Peterson, R. T. (2014). Zebraﬁsh models of cerebrovascular
disease. J. Cereb. Blood Flow Metab. 34, 571–577. doi: 10.1038/jcbfm.2014.27
Wang, C., Wu, C., Popescu, D. C., Zhu, J., Macklin, W. B., Miller, R. H., et al. (2011).
Longitudinal near-infrared imaging of myelination. J. Neurosci. 31, 2382–2390.
doi: 10.1523/JNEUROSCI.2698-10.2011
Weerakkody, T. N., Patel, T. P., Yue, C., Takano, H., Anderson, H. C., Meaney, D.
F., et al. (2013). Engraftment of nonintegrating neural stem cells differentially
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 226 | 9
Aswendt et al. Optical neuroimaging in stroke therapy
perturbs cortical activity in a dose-dependent manner. Mol. Ther. 21, 2258–2267.
doi: 10.1038/mt.2013.163
Weissleder, R., and Gambhir, S. S. (2010). Molecular Imaging: Principles and Practice.
Shelton: Peoples Medical Publishing House.
Witte, S., Negrean, A., Lodder, J. C., de Kock, C. P., Testa Silva, G., Mansvelder, H.
D., et al. (2011). Label-free live brain imaging and targeted patching with third-
harmonic generation microscopy. Proc. Natl. Acad. Sci. U.S.A. 108, 5970–5975.
doi: 10.1073/pnas.1018743108
Xu, R., Feyeux, M., Julien, S., Nemes, C., Albrechtsen, M., Dinnyés, A., et al.
(2014). Screening of bioactive peptides using an embryonic stem cell-based
neurodifferentiation assay. AAPS J. 16, 400–412. doi: 10.1208/s12248-014-9578-7
Zhang, S., andMurphy,T.H. (2007). Imaging the impact of corticalmicrocirculation
on synaptic structure and sensory-evoked hemodynamic responses in vivo. PLoS
Biol. 5:e119. doi: 10.1371/journal.pbio.0050119
Zhang, Y., Fan, S., Yao, Y., Ding, J., Wang, Y., Zhao, Z., et al. (2012). In vivo near-
infrared imaging of ﬁbrin deposition in thromboembolic stroke in mice. PLoS
ONE 7:e30262. doi: 10.1371/journal.pone.0030262
Zhang, Z. G., and Chopp, M. (2009). Neurorestorative therapies for stroke: under-
lying mechanisms and translation to the clinic. Lancet Neurol. 8, 491–500. doi:
10.1016/S1474-4422(09)70061-4
Zhao, H., Doyle, T. C., Coquoz, O., Kalish, F., Rice, B. W., and Contag, C. H. (2005).
Emission spectra of bioluminescent reporters and interaction with mammalian
tissue determine the sensitivity of detection in vivo. J. Biomed. Opt. 10, 41210.
doi: 10.1117/1.2032388
Conflict of Interest Statement:The authors declare that the research was conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 22 May 2014; accepted: 22 July 2014; published online: 14 August 2014.
Citation: Aswendt M, Adamczak J and Tennstaedt A (2014) A review of novel optical
imaging strategies of the stroke pathology and stem cell therapy in stroke. Front. Cell.
Neurosci. 8:226. doi: 10.3389/fncel.2014.00226
This article was submitted to the journal Frontiers in Cellular Neuroscience.
Copyright © 2014 Aswendt, Adamczak and Tennstaedt. This is an open-access article
distributed under the terms of the Creative CommonsAttribution License (CCBY). The
use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 226 | 10
